8 Follicular Lymphoma Clinical Trials in Phoenix, AZ (2026)

Q: How do I join a clinical trial in Phoenix?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Phoenix research site will contact you.

Recruiting Follicular Lymphoma Studies in Phoenix

NCT07805707Recruiting

A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age

This study will compare an investigational mRNA flu vaccine with a licensed flu vaccine in adults 65 years of age and older. Participants will receive one injection and will be followed during the flu...

Phoenix, AZPHASE354,000 participantsGlaxoSmithKline

View Study Details

NCT07159763Recruiting

A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza

The purpose of this study is to evaluate how well CD388 works in preventing symptomatic laboratory-confirmed influenza infections, as compared to placebo, when given as a single dose via 3 subcutaneou...

Phoenix, AZPHASE310,000 participantsCidara Therapeutics Inc.

View Study Details

NCT06549595Recruiting

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

This is a global, randomised, Phase III, multicentre, open-label study evaluating the efficacy, safety and the degree of added benefit of the Surovatamig (AZD0486) plus rituximab combination compared ...

Phoenix, AZPHASE31,018 participantsAstraZeneca

View Study Details

NCT06337318Recruiting

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

This phase III trial compares the effectiveness of rituximab to mosunetuzumab in treating patients with follicular lymphoma with a low tumor burden. Rituximab is a monoclonal antibody. It binds to a p...

Phoenix, AZPHASE3600 participantsNational Cancer Institute (NCI)

View Study Details

NCT05895786Recruiting

A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]

The purpose of the study is to understand how the study medicine PF-06823859 works in people with idiopathic inflammatory myopathies (DM and PM). These disorders cause inflammation that weakens the mu...

Phoenix, AZPHASE3318 participantsPfizer

View Study Details

NCT06858579Recruiting

A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

The purpose of this Phase 3 study is to demonstrate the efficacy of DNTH103 as compared to placebo in participants with chronic inflammatory demyelinating polyneuropathy (CIDP)....

Phoenix, AZPHASE3256 participantsDianthus Therapeutics

View Study Details

NCT06455449Recruiting

A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)

The purpose of this multicenter, randomized, placebo-controlled and double-blind study is to evaluate the efficacy and safety of subcutaneous anifrolumab compared with placebo on the overall disease a...

Phoenix, AZPHASE3240 participantsAstraZeneca

View Study Details

NCT02055105Recruiting

Modulation of Molecular Fingerprinting in Pediatric Sepsis

The goal of this study is to demonstrate the sensitivity and specificity of detecting circulating micro RNA (miRNA) biomarkers in pediatric septic patients. It will also follow expression and modulati...

Phoenix, AZ50 participantsPhoenix Children's Hospital

View Study Details

About Follicular Lymphoma Clinical Trials in Phoenix

Follicular lymphoma is the second most common type of non-Hodgkin lymphoma and is typically a slow-growing (indolent) cancer. It develops from B-cells in the lymph nodes. Treatment ranges from watchful waiting to immunotherapy, chemotherapy, and targeted agents.

There are currently 8 follicular lymphoma clinical trials recruiting participants in Phoenix, AZ. These studies are seeking a combined 66,482 participants. Research is being sponsored by GlaxoSmithKline, Cidara Therapeutics Inc., AstraZeneca and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Follicular Lymphoma Clinical Trials in Phoenix — FAQ

Are there follicular lymphoma clinical trials in Phoenix?

Yes, there are 8 follicular lymphoma clinical trials currently recruiting in Phoenix, AZ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Phoenix?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Phoenix research site will contact you about next steps.

Are clinical trials in Phoenix free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Phoenix studies also compensate for your time and travel.

What follicular lymphoma treatments are being tested?

The 8 active trials in Phoenix are testing new therapies including novel drugs, biologics, and treatment approaches for follicular lymphoma.

Data updated October 15, 2026 from ClinicalTrials.gov